Allison Luo

2021

In 2021, Allison Luo earned a total compensation of $4.2M as Chief Medical Officer at Prometheus Biosciences, a 305% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$364,800
Option Awards$3,407,763
Salary$450,187
Other$12,986
Total$4,235,736

Luo received $3.4M in option awards, accounting for 80% of the total pay in 2021.

Luo also received $364.8K in non-equity incentive plan, $450.2K in salary and $13K in other compensation.

Rankings

In 2021, Allison Luo's compensation ranked 3,143rd out of 12,415 executives tracked by ExecPay. In other words, Luo earned more than 74.7% of executives.

ClassificationRankingPercentile
All
3,143
out of 12,415
75th
Division
Manufacturing
1,268
out of 5,505
77th
Major group
Chemicals And Allied Products
517
out of 2,375
78th
Industry group
Drugs
458
out of 2,096
78th
Industry
Pharmaceutical Preparations
316
out of 1,546
80th
Source: SEC filing on April 1, 2022.

Luo's colleagues

We found three more compensation records of executives who worked with Allison Luo at Prometheus Biosciences in 2021.

2021

Mark McKenna

Prometheus Biosciences

Chief Executive Officer

2021

Keith Marshall

Prometheus Biosciences

Chief Financial Officer

2021

Mark Stenhouse

Prometheus Biosciences

Chief Operating Officer

News

In-depth

You may also like